← Back to Clinical Trials
Recruiting NCT06351046

NCT06351046 Preventive Interventions for Chronic Pain Worsening

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06351046
Status Recruiting
Phase —
Sponsor Copenhagen University Hospital, Rigshospitalet
Condition Chronic Non-Cancer Pain
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-05-14
Primary Completion 2027-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Virtual Reality-based Pain Self-management program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-05-14 with a primary completion date of 2027-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is an open label randomized controlled trial (RCT), which will be conducted with patients of the Copenhagen Wound Healing Center at Bispebjerg Hospital in Copenhagen (DK). The trial has two arms (1:1): A Virtual Reality based Pain Self-management (VRPS) program group, and a control group (usual care). Included will be 44 patients at least 18 years old; fluent in the Danish language; complaint of pain lasting 3 months or more; in average pain intensity score ≥ 3 (numerical rating scale 0 to 10); access to internet; and willing and available to participate in the study. Excluded will be specialized or multidisciplinary pain treatment at baseline; history of epilepsy, seizure disorder, nausea or dizziness, hypersensitivity to flashing light or motion or other diseases that may prevent use of virtual reality equipment; injury to eyes, face or neck.

Eligibility Criteria

Inclusion Criteria: * At least 18 years old * Fluent in the Danish language * Complaint of pain lasting 3 months or more; in average pain intensity score ≥ 3 (numerical rating scale 0 to 10) * Access to internet * Willing and available to participate in the study. Exclusion Criteria: * Specialized or multidisciplinary pain treatment at baseline * History of epilepsy * Seizure disorder * History of nausea or dizziness * Hypersensitivity to flashing light or motion or other diseases that may prevent use of virtual reality equipment. * Injury to eyes, face or neck that impedes comfortable use of virtual reality equipment. * Current cancer disease * Medical diagnosis of depression * Cognitive dysfunction that interferers with compliance to the study, * Currently pregnant or planning to become pregnant during the study period * No access to the internet during the study period.

Contact & Investigator

Central Contact

Geana Kurita, PhD

✉ geana.kurita@regionh.dk

📞 35454797

Principal Investigator

Geana Kurita, PhD

PRINCIPAL INVESTIGATOR

Copenhagen University Hospital, Rigshospitalet

Frequently Asked Questions

Who can join the NCT06351046 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Non-Cancer Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06351046 currently recruiting?

Yes, NCT06351046 is actively recruiting participants. Contact the research team at geana.kurita@regionh.dk for enrollment information.

Where is the NCT06351046 trial being conducted?

This trial is being conducted at Copenhagen, Denmark.

Who is sponsoring the NCT06351046 clinical trial?

NCT06351046 is sponsored by Copenhagen University Hospital, Rigshospitalet. The principal investigator is Geana Kurita, PhD at Copenhagen University Hospital, Rigshospitalet. The trial plans to enroll 44 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology